Stromal aminopeptidase N expression: Correlation with angiogenesis in non-small-cell lung cancer

General Thoracic and Cardiovascular Surgery

Volumn 57, Issue 11, 2009, Pages 591-598

  Ito, Shinya ^a   Miyahara, Ryo ^a   Takahashi, Rei ^a   Nagai, Shinjiro ^a   Takenaka, Kazumasa ^a   Wada, Hiromi ^a   Tanaka, Fumihiro ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Aminopeptidase N; Angiogenesis; CD13; Non small cell lung cancer; Stroma

Indexed keywords

CISPLATIN; MICROSOMAL AMINOPEPTIDASE; UFT;

ADULT; ANGIOGENESIS; ARTICLE; DENSITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MICROVESSEL DENSITY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STROMA CELL; SURVIVAL RATE; TUMOR CELL;

ADENOCARCINOMA; AGED; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LEUCINE; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PNEUMONECTOMY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 73349117829     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-009-0445-x     Document Type: Article

References (21)

1. J. Dixon L. Kaklamanis H. Turley I.D. Hickson R.D. Leek A.L. Harris, et al. 1994 Expression of aminopeptidase-N (CD13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin J Clin Pathol 47 43 47 10.1136/jcp.47.1.43 1:STN:280:DyaK2c7nvFGhtQ%3D%3D 7907609
2. H. Hashida A. Takabayashi M. Kanai M. Adachi K. Kondo N. Kohno, et al. 2002 Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer Gastroenterology 122 376 386 10.1053/gast.2002.31095 1:CAS:528:DC%2BD38XhsVGns7s%3D 11832452
3. N. Ikeda Y. Nakajima T. Tokuhara N. Hattori M. Sho H. Kanehiro, et al. 2003 Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma Clin Cancer Res 9 1503 1508 1:CAS:528:DC%2BD3sXislertbg%3D 12684426
4. T. Tokuhara M. Adachi H. Hashida H. Ishida T. Taki M. Higashiyama, et al. 2001 Neutral endopeptidase/CD10 and ami nopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer Jpn J Thorac Cardiovasc Surg 49 489 496 10.1007/BF02919543 1:STN:280:DC%2BD3Mrgt1GqsQ%3D%3D 11552274
5. C.F. Mountain 1997 Revisions in the international system for lung cancer Chest 111 1710 1717 10.1378/chest.111.6.1710 1:STN:280:DyaK2szjtVOguw%3D%3D 9187198
6. F. Tanaka Y. Kawano M. Li T. Takata R. Miyahara K. Yanagihara, et al. 1999 Prognostic significance of apoptotic index in completely resected non-small cell lung cancer J Clin Oncol 17 2728 2736 1:STN:280:DC%2BD3c%2FjtVSktA%3D%3D 10561347
7. F. Tanaka Y. Otake K. Yanagihara Y. Kawano R. Miyahara M. Li, et al. 2001 Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti- CD105 antibody Clin Cancer Res 7 3410 3415 1:CAS:528:DC%2BD3MXptFaisr0%3D 11705856
8. F. Tanaka S. Ishikawa K. Yanagihara R. Miyahara Y. Kawano M. Li, et al. 2002 Expression of angiopoietins and its clinical significance in non-small cell lung cancer Cancer Res 62 7124 7129 1:CAS:528:DC%2BD38XpsVaht78%3D 12460935 (Pubitemid 35424109)
9. S. Ishikawa K. Takenaka K. Yanagihara R. Miyahara Y. Kawano Y. Otake, et al. 2004 Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer Clin Cancer Res 10 6579 6585 10.1158/1078-0432.CCR-04-0272 1:CAS:528: DC%2BD2cXot1Oiurc%3D 15475447 (Pubitemid 39346554)
10. E. Ogawa K. Takenaka K. Yanagihara M. Kurozumi T. Manabe H. Wada, et al. 2004 Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients Br J Cancer 91 498 503 10.1038/sj.bjc.6601992 1:CAS:528:DC%2BD2cXlvF2lsbk%3D 15226767 (Pubitemid 39093569)
11. Y. Ichinose K. Genka T. Koike H. Kato Y. Watanabe T. Mori, et al. 2003 NK421 Lung Cancer Surgery Group: randomized double-blind placebo-controlled trial of Bestatin in patients with resected stage I squamous-cell lung carcinoma J Natl Cancer Inst 95 605 610 1:CAS:528:DC%2BD3sXjtFWqsb4%3D 12697853
12. K. Ezawa K. Minato K. Dobashi 1996 Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines Biomed Pharmacother 50 283 289 10.1016/0753-3322(96)84827-X 1:CAS:528:DyaK28XmvFKiu7k%3D 8952869 (Pubitemid 26330287)
13. K. Inoi S. Goto S. Nomura K. Isobe A. Nawa T. Okamoto, et al. 1995 Aminopeptidase inhibitor ubenimex (Bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity Anticancer Res 15 2081 2087 1:STN:280:DyaK287lt1CntQ%3D%3D 8572606
14. J.E. Talmadge B.F. Lenz R. Pennington C. Long H. Phillips M. Schneider, et al. 1986 Immunomodulatory and therapeutic properties of Bestatin in mice Cancer Res 46 4505 4510 1:CAS:528:DyaL28Xls1CltrY%3D 2942238
15. H. Tsukamoto K. Shibata H. Kajiyama M. Terauchi A. Nawa F. Kikkawa 2008 Aminopeptidase N (APN)/CD13 inhibitor, ubenimex, enhances radiation sensitivity in human cervical cancer BMC Cancer 19 74 81 10.1186/1471-2407-8-74
16. D. Hanahan J. Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364 10.1016/S0092-8674(00) 80108-7 1:CAS:528:DyaK28XltVSks7s%3D 8756718 (Pubitemid 26272076)
17. H. Fujii M. Nakajima T. Aoyagi T. Tsuruo 1996 Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors Biol Pharm Bull 19 6 10 1:CAS:528:DyaK28XnvVelsw%3D%3D 8820902
18. R. Pasqualini E. Koivunen R. Kain J. Lahdenranta M. Sakamoto A. Stryhn, et al. 2000 Aminopeptidase N is a receptor for tumorhoming peptides and a target for inhibiting angiogenesis Cancer Res 60 722 727 1:CAS:528: DC%2BD3cXht1Gmtbc%3D 10676659
19. S.V. Bhagwat J. Lahdenranta R. Giordano W. Arap R. Pasqualini L.H. Shapiro 2001 CD13/APN is activated by angiogenic signals and is essential for capillary tube formation Blood 97 652 659 10.1182/blood.V97.3.652 1:CAS:528:DC%2BD3MXhtVSjsLg%3D 11157481 (Pubitemid 32113397)
20. F. Curnis A. Sacchi L. Borgna F. Magni A. Gasparri A. Corti 2000 Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) Nat Biotechnol 2 18 1185 1190 10.1038/81183 1:CAS:528:DC%2BD3cXotVSltrY%3D (Pubitemid 30823358)
21. F. Curnis G. Arrigoni A. Sacchi L. Fischetti W. Arap R. Pasqualini, et al. 2002 Differential binding of drugs containing the NGR motif to CD 13 isoforms in tumor vessels, epithelia, and myeloid cells Cancer Res 62 867 874 1:CAS:528:DC%2BD38Xht1Kqsr8%3D 11830545